Unprecedented Research Results Clinical studies show that retatrutide 10mg peptide achieves an average of 28.7% weight loss, greatly surpassing tirzepatide (22.5%) and semaglutide (15%) in comparative research
(PubMed) Ernster L, Dallner G
Studies have shown it modulates the expression of over 4,000 human genes shifting the expression profile toward a younger phenotype
In the immediate future, the food industry will remain resilient, and companies will find ways to seize new opportunities
APPETITE SUPPRESSION AND HUNGER SIGNAL INHIBITION When cagrilintide activates GIP receptors in the hypothalamus and other brain regions involved in appetite control, it triggers suppression of orexigenic (hunger-promoting) neuropeptides and enhancement of anorexigenic (appetite-suppressing) pathways
It is present in every cell of the body, where it provides potent antioxidant protection, supports detoxification, and modulates the immune system